Related publications

Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, Costiniuk C, Blank D, Schünemann H. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database of Systematic Reviews 2011, Issue 3.

Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, Costiniuk C, Blank D, Schünemann H. Framing of health information messages. Cochrane Database of Systematic Reviews 2011, Issue 11.

Atkins S, Lewin S, Jordaan S, Thorson A. Lay health worker supported tuberculosis treatment adherence in South Africa: an interrupted time series study. International Journal of Tuberculosis and Lung Disease. 2010; 15(1): 84-89.

Attaran A, Pang T, Whitworth J, Oxman A, McKee M. Healthy by law: the missed opportunity to use laws for public health. Lancet 2011; DOI:10.1016/S0140-6736(11)60069-X

Balshem H, Helfand M, Schunemann H, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines 3. Rating the quality of evidence – introduction. J Clin Epidemiol 2011; 64:401-6.

Brunetti M, Ruiz F, Lord J, Pregno S, Oxman AD. Grading economic evidence. In: Shemilt E, Mugford M, Vale L, Marsh K, Donaldson C (editors), Evidence-Based Decisions and Economics, 2nd Edition. Oxford: Wiley-Blackwell, 2010.

Cliff J, Lewin S, Woelk G, Fernandes B, Mariano A, Sevene E, Daniels K, Matinhure S, Oxman AD, Lavis JN. Policy development in malaria vector management in Mozambique, South Africa and Zimbabwe. Health Policy and Planning 2010;25:372-83.

Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, Jamtvedt G, Farmer A, Ghersi D, Groves T, Heneghan C, Hill S, Lewin S, Michie S, Perera R, Pomeroy V, Tilson J, Shepperd S, Williams JW. Taking healthcare interventions from trial to practice. BMJ. 2010 Aug 13;341:c3852.

Guyatt GH, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64:383-94.

Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400.

Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Devereaux PJ, et al. GRADE guidelines 6. Rating the quality of evidence – imprecision. J Clin Epidemiol 2011; doi: 10.1016/j.jclinepi.2011.01.012

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines 7. Rating the quality of evidence - inconsistency. J Clin Epidemiol 2011; doi: 10.1016/j.jclinepi.2011.03.017

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines 8. Rating the quality of evidence - indirectness. J Clin Epidemiol 2011; doi: 10.1016/j.jclinepi.2011.04.014

Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines - 5. Rating the quality of evidence - publication bias. J Clin Epidemiol 2011; doi: 10.1016/j.jclinepi.2011.01.011

Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knotterus A. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64:380-2.

Guyatt GH, Oxman AD, Sultan S, Glasziou P, Alonso-Coello P, Atkins D, et al. GRADE guidelines 9. Rating up the quality of evidence. J Clin Epidemiol 2011; doi: 10.1016/j.jclinepi.2011.06.004

Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines 4. Rating the quality of evidence - study limitations (risk of bias). J Clin Epidemiol 2011; 64:407-15.

Higgins JPT, Altman DG, Gøtzsche PC, Moher D, Oxman AD, Savovic J, Schulz K, Weeks L, Sterne JAC, Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ 2011; 343:889-93.

Leon N, Colvin C, Lewin S, Mathews C, Jennings K. Provider-initiated testing and counseling for HIV: from debate to implementation. South African Medical Journal. 2010; 100(4): 220-221.

Leon N, Naidoo P, Mathews C, Lewin S, Lombard C. The impact of Provider-Initiated (Opt-out) HIV Testing and Counselling of patients with sexually transmitted infection in Cape Town, South Africa. A controlled trial. Implementation Science. 2010; 5:8.

Odgaard-Jensen J, Vist GE, Timmer A, Kunz R, Akl EA, Schünemann H, Briel M, Nordmann AJ, Pregno S, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database of Systematic Reviews 2011, Issue 4.

Oxman AD, Bjørndal A, Becerra-Posada F, Gibson M, Gonzalez Block MA, Haines A, Hamid M, Hooker Odom C, Lei H, Levin B, Lipsey MW, Littell JH, Mshinda H, Ongolo-Zogo P, Pang T, Sewankambo N, Songane F, Soydan H, Torgerson C, Weisburd D, Whitworth J, Wibulpolprasert S. A framework for mandatory impact evaluation to ensure well informed public policy decisions. Lancet. 2010; 375:427–31.

Oxman AD, Yohannes AM, Røttingen JA. Options for improving malaria treatment: Introduction. Options for improving malaria treatment: Introduction. International Journal of Technology Assessment in Health Care 2010; 26:228.

Rosenbaum SE, Glenton C, Nylund HK, Oxman AD. User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane Reviews. J Clin Epidemiol 2010; 63:607-19.

Rosenbaum SE, Glenton C, Oxman AD. Summary of Findings tables improved understanding and rapid retrieval of key information in Cochrane Reviews. J Clin Epidemiol 2010; 63:620-6.

Rosenbaum SE, Glenton C, Wiysonge CS, Abalos E, Mignini L, Young T, Althabe F, Ciapponi A, Garcia Marti S, Meng Q, Wang J, De la Hoz Bradford AM, Kiwanuka S, Rutebemberwa E, Flottorp S, Oxman AD. Evidence summaries tailored for health policymakers in low and middle-income countries. WHO Bull 2011¸89:54-61.

Wensing M, Oxman AD, Baker R, Godycki-Cwirko M, Flottorp S, Szecsenyi J, Grimshaw J, Eccles M. Tailored Implementation for chronic diseases (TICD): a project protocol. Implementation Science 2011, 6:103.